Novo Nordisk A/S (NVO) closed fiscal year 2025 with 4.44 B shares outstanding and a dividend of 1.68 USD per share.
Novo Nordisk A/S (NVO) closed fiscal year 2025 with 4.44 B shares outstanding and a dividend of 1.68 USD per share. Over the year the share count rose by 2.14 M shares on a net basis, typically through stock-based compensation and options. Since 2022 the share count has shrunk by 1.3 %. The dividend per share was 1.68 USD, up 16.6 % year on year. Total dividends paid came to 8.17 B USD, spread over 2 payments. The series covers 4 fiscal years, from 2022 to 2025. Per-share amounts are stated in USD. Share counts and dividends come from the company's own published annual accounts, with no restatements or adjustments of our own.
Fiscal year end: December
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Shares outstanding, year-end | 4.50B | 4.46B | 4.44B | 4.44B |
| Shares issued — SBC/options | — | 0.00M | 0.00M | 2.14M |
| Shares issued (%) | — | 0.00 % | 0.00 % | 0.05 % |
| Shares repurchased | — | -41.5M | -16.9M | 0.00M |
| Shares repurchased (%) | — | -0.93 % | -0.38 % | 0.00 % |
| Net addition/reduction | — | -41.5M | -16.9M | 2.14M |
| Net addition/reduction (%) | — | -0.93 % | -0.38 % | 0.05 % |
Fiscal year end: December
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Dividend per share (DPS) | 0.81 | 1.04 | 1.44 | 1.68 |
| Payout Ratio (%) | 45.57 % | 37.96 % | 43.71 % | 50.53 % |
| Number of payments | 2.00 | 2.00 | 2.00 | 2.00 |
| Dividends paid (total) | 3.62B | 4.73B | 6.17B | 8.17B |
| Dividend Yield (%) | 1.21 % | 1.00 % | 1.65 % | 3.21 % |
Figures in USD
